{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:37:17Z","timestamp":1794652637182,"version":"4.9.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Union \u2013 Next Generation EU","award":["LX22NPO5107"],"award-info":[{"award-number":["LX22NPO5107"]}]},{"name":"European Union \u2013 Next Generation EU","award":["LX22NPO5107"],"award-info":[{"award-number":["LX22NPO5107"]}]},{"name":"European Union \u2013 Next Generation EU","award":["LX22NPO5107"],"award-info":[{"award-number":["LX22NPO5107"]}]},{"name":"European Union \u2013 Next Generation EU","award":["LX22NPO5107"],"award-info":[{"award-number":["LX22NPO5107"]}]},{"name":"European Union \u2013 Next Generation EU","award":["LX22NPO5107"],"award-info":[{"award-number":["LX22NPO5107"]}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["CZ-DRO-VFN00064165"],"award-info":[{"award-number":["CZ-DRO-VFN00064165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["CZ-DRO-VFN00064165"],"award-info":[{"award-number":["CZ-DRO-VFN00064165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["CZ-DRO-NNH 23884"],"award-info":[{"award-number":["CZ-DRO-NNH 23884"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["CZ-DRO-VFN00064165"],"award-info":[{"award-number":["CZ-DRO-VFN00064165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["CZ-DRO-VFN00064165"],"award-info":[{"award-number":["CZ-DRO-VFN00064165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["CZ-DRO-VFN00064165"],"award-info":[{"award-number":["CZ-DRO-VFN00064165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU21-04-00535"],"award-info":[{"award-number":["NU21-04-00535"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Quantitative MRI techniques, including quantitative susceptibility mapping (QSM) and diffusion tensor imaging (DTI), may detect early neurodegenerative changes in \u0251-synucleinopathies, especially within the midbrain. This study evaluated their potential to predict phenoconversion to overt synucleinopathy in 79 patients with isolated REM sleep behavior disorder (iRBD) followed annually over 5.6\u2009\u00b1\u20093.0 years. Phenoconversion, defined by emergence of parkinsonism or dementia, occurred in 21 patients. Baseline QSM and DTI data were analyzed to identify regional brain differences, revealing increased magnetic susceptibility and fractional anisotropy (FA) in the bilateral cerebral peduncle of phenoconverters. Increased magnetic susceptibility and FA within this region were associated with higher phenoconversion risk (FA: hazard ratio (HR)\u2009=\u20091.84, susceptibility: HR\u2009=\u20091.67). Their combined score predicted phenoconversion with accuracy similar to dopamine-transporter imaging (HR 2.58 vs 2.85). Findings suggest that increased susceptibility and FA in the cerebral peduncle may serve as biomarkers of early phenoconversion, potentially reflecting compensatory neuroplastic changes in subthalamo-pallidal pathways.<\/jats:p>","DOI":"10.1038\/s41531-025-01174-x","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:41:40Z","timestamp":1763728900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Susceptibility and diffusion MRI biomarkers predict development of Parkinsonism in iRBD"],"prefix":"10.1038","volume":"11","author":[{"given":"Zsoka","family":"Varga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Nepozitek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hlavnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhineet","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Pantano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Marecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Sonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Dusek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"1174_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1212\/WNL.46.2.388","volume":"46","author":"CH Schenck","year":"1996","unstructured":"Schenck, C. H., Bundlie, S. R. & Mahowald, M. W. Delayed emergence of a Parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46, 388\u2013393 (1996).","journal-title":"Neurology"},{"key":"1174_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1474-4422(16)00057-0","volume":"15","author":"A Iranzo","year":"2016","unstructured":"Iranzo, A., Santamaria, J. & Tolosa, E. Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurol. 15, 405\u2013419 (2016).","journal-title":"Lancet Neurol."},{"key":"1174_CR3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1212\/01.wnl.0000340980.19702.6e","volume":"72","author":"RB Postuma","year":"2009","unstructured":"Postuma, R. B. et al. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 72, 1296\u20131300 (2009).","journal-title":"Neurology"},{"key":"1174_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1212\/WNL.0b013e3181ec7fac","volume":"75","author":"DO Claassen","year":"2010","unstructured":"Claassen, D. O. et al. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century(e\u2013Pub ahead of print)(CME). Neurology 75, 494\u2013499 (2010).","journal-title":"Neurology"},{"key":"1174_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1474-4422(21)00176-9","volume":"20","author":"MG Miglis","year":"2021","unstructured":"Miglis, M. G. et al. Biomarkers of conversion to \u03b1-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder. Lancet Neurol. 20, 671\u2013684 (2021).","journal-title":"Lancet Neurol."},{"key":"1174_CR6","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1002\/jnr.25099","volume":"100","author":"M Valli","year":"2022","unstructured":"Valli, M., Uribe, C., Mihaescu, A. & Strafella, A. P. Neuroimaging of rapid eye movement sleep behavior disorder and its relation to Parkinson\u2019s disease. J. Neurosci. Res. 100, 1815\u20131833 (2022).","journal-title":"J. Neurosci. Res."},{"key":"1174_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/bs.irn.2018.10.006","volume":"144","author":"P-A Bourgouin","year":"2019","unstructured":"Bourgouin, P.-A. et al. Neuroimaging of rapid eye movement sleep behavior disorder. Int. Rev. Neurobiol. 144, 185\u2013210 (2019).","journal-title":"Int. Rev. Neurobiol."},{"key":"1174_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.smrv.2016.06.006","volume":"34","author":"J Heller","year":"2017","unstructured":"Heller, J. et al. Brain imaging findings in idiopathic REM sleep behavior disorder (RBD)\u2014a systematic review on potential biomarkers for neurodegeneration. Sleep. Med. Rev. 34, 23\u201333 (2017).","journal-title":"Sleep. Med. Rev."},{"key":"1174_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.mri.2015.02.021","volume":"33","author":"JHO Barbosa","year":"2015","unstructured":"Barbosa, J. H. O. et al. Quantifying brain iron deposition in patients with Parkinson\u2019s disease using quantitative susceptibility mapping, R2 and R2*. Magn. Reson. Imaging 33, 559\u2013565 (2015).","journal-title":"Magn. Reson. Imaging"},{"key":"1174_CR10","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1002\/hbm.22928","volume":"36","author":"N He","year":"2015","unstructured":"He, N. et al. Region-specific disturbed iron distribution in early idiopathic Parkinson\u2019s disease measured by quantitative susceptibility mapping. Hum. Brain Mapp. 36, 4407\u20134420 (2015).","journal-title":"Hum. Brain Mapp."},{"key":"1174_CR11","doi-asserted-by":"publisher","first-page":"e0162460","DOI":"10.1371\/journal.pone.0162460","volume":"11","author":"C Langkammer","year":"2016","unstructured":"Langkammer, C. et al. Quantitative susceptibility mapping in Parkinson\u2019s disease. PLoS ONE 11, e0162460 (2016).","journal-title":"PLoS ONE"},{"key":"1174_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-981-13-9589-5_4","volume":"1173","author":"H Jiang","year":"2019","unstructured":"Jiang, H., Song, N., Jiao, Q., Shi, L. & Du, X. Iron pathophysiology in Parkinson diseases. Adv. Exp. Med. Biol. 1173, 45\u201366 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1174_CR13","first-page":"181","volume":"127","author":"H Mochizuki","year":"2020","unstructured":"Mochizuki, H., Choong, C.-J. & Baba, K. Parkinson\u2019s disease and iron. J. Neural Transm. Vienna Austria 1996 127, 181\u2013187 (2020).","journal-title":"J. Neural Transm. Vienna Austria 1996"},{"key":"1174_CR14","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1212\/01.wnl.0000286384.31050.b5","volume":"70","author":"WRW Martin","year":"2008","unstructured":"Martin, W. R. W., Wieler, M. & Gee, M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70, 1411\u20131417 (2008).","journal-title":"Neurology"},{"key":"1174_CR15","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/jon.12878","volume":"31","author":"Q Chen","year":"2021","unstructured":"Chen, Q. et al. MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body disease. J. Neuroimaging 31, 1020\u20131027 (2021).","journal-title":"J. Neuroimaging"},{"key":"1174_CR16","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.parkreldis.2014.03.023","volume":"20","author":"J-H Lee","year":"2014","unstructured":"Lee, J.-H. et al. Evaluation of brain iron content in idiopathic REM sleep behavior disorder using quantitative magnetic resonance imaging. Parkinsonism Relat. Disord. 20, 776\u2013778 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1174_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/acn3.50962","volume":"7","author":"TR Barber","year":"2020","unstructured":"Barber, T. R. et al. Nigrosome 1 imaging in REM sleep behavior disorder and its association with dopaminergic decline. Ann. Clin. Transl. Neurol. 7, 26\u201335 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1174_CR18","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/mds.27929","volume":"35","author":"J Sun","year":"2020","unstructured":"Sun, J. et al. Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder. Mov. Disord. 35, 478\u2013485 (2020).","journal-title":"Mov. Disord."},{"key":"1174_CR19","doi-asserted-by":"publisher","first-page":"119454","DOI":"10.1016\/j.neuroimage.2022.119454","volume":"260","author":"M Lancione","year":"2022","unstructured":"Lancione, M. et al. Evaluation of iron overload in nigrosome 1 via quantitative susceptibility mapping as a progression biomarker in prodromal stages of synucleinopathies. NeuroImage 260, 119454 (2022).","journal-title":"NeuroImage"},{"key":"1174_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-022-00430-8","volume":"9","author":"J Nepozitek","year":"2023","unstructured":"Nepozitek, J. et al. Magnetic susceptibility changes in the brainstem reflect REM sleep without atonia severity in isolated REM sleep behavior disorder. npj Park. Dis. 9, 1\u20138 (2023).","journal-title":"npj Park. Dis."},{"key":"1174_CR21","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1073\/pnas.0910222107","volume":"107","author":"J Lee","year":"2010","unstructured":"Lee, J. et al. Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. Proc. Natl Acad. Sci. 107, 5130\u20135135 (2010).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1174_CR22","doi-asserted-by":"publisher","first-page":"531993","DOI":"10.3389\/fneur.2020.531993","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. & Burock, M. A. Diffusion tensor imaging in parkinson\u2019s disease and Parkinsonian syndrome: a systematic review. Front. Neurol. 11, 531993 (2020).","journal-title":"Front. Neurol."},{"key":"1174_CR23","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1002\/mds.26325","volume":"30","author":"N Schuff","year":"2015","unstructured":"Schuff, N. et al. Diffusion imaging of nigral alterations in early Parkinson\u2019s disease with dopaminergic deficits. Mov. Disord. 30, 1885\u20131892 (2015).","journal-title":"Mov. Disord."},{"key":"1174_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/brain.2017.0558","volume":"8","author":"N-K Chen","year":"2018","unstructured":"Chen, N.-K. et al. Alteration of diffusion-tensor magnetic resonance imaging measures in brain regions involved in early stages of Parkinson\u2019s disease. Brain Connect. 8, 343\u2013349 (2018).","journal-title":"Brain Connect."},{"key":"1174_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ana.22245","volume":"69","author":"C Scherfler","year":"2011","unstructured":"Scherfler, C. et al. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann. Neurol. 69, 400\u2013407 (2011).","journal-title":"Ann. Neurol."},{"key":"1174_CR26","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/sleep\/33.6.767","volume":"33","author":"MM Unger","year":"2010","unstructured":"Unger, M. M. et al. Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions. Sleep 33, 767\u2013773 (2010).","journal-title":"Sleep"},{"key":"1174_CR27","doi-asserted-by":"publisher","first-page":"zsx149","DOI":"10.1093\/sleep\/zsx149","volume":"40","author":"N Pyatigorskaya","year":"2017","unstructured":"Pyatigorskaya, N. et al. Magnetic resonance imaging biomarkers to assess substantia nigra damage in idiopathic rapid eye movement sleep behavior disorder. Sleep 40, zsx149 (2017).","journal-title":"Sleep"},{"key":"1174_CR28","doi-asserted-by":"publisher","first-page":"zsaa199","DOI":"10.1093\/sleep\/zsaa199","volume":"44","author":"F Holtbernd","year":"2021","unstructured":"Holtbernd, F. et al. Convergent patterns of structural brain changes in rapid eye movement sleep behavior disorder and Parkinson\u2019s disease on behalf of the German rapid eye movement sleep behavior disorder study group. Sleep 44, zsaa199 (2021).","journal-title":"Sleep"},{"key":"1174_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/brain\/awaa365","volume":"144","author":"D Arnaldi","year":"2020","unstructured":"Arnaldi, D. et al. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder. Brain 144, 278 (2020).","journal-title":"Brain"},{"key":"1174_CR30","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/ana.26902","volume":"95","author":"D Arnaldi","year":"2024","unstructured":"Arnaldi, D. et al. Presynaptic dopaminergic imaging characterizes patients with REM sleep behavior disorder due to synucleinopathy. Ann. Neurol. 95, 1178\u20131192 (2024).","journal-title":"Ann. Neurol."},{"issue":"Pt 5","key":"1174_CR31","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley, J. M. & Lees, A. J. Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain J. Neurol. 114(Pt 5), 2283\u20132301 (1991).","journal-title":"Brain J. Neurol."},{"key":"1174_CR32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/ana.22284","volume":"69","author":"R de la Fuente-Fern\u00e1ndez","year":"2011","unstructured":"de la Fuente-Fern\u00e1ndez, R. et al. Age-specific progression of nigrostriatal dysfunction in Parkinson\u2019s disease. Ann. Neurol. 69, 803\u2013810 (2011).","journal-title":"Ann. Neurol."},{"key":"1174_CR33","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1093\/brain\/awaa216","volume":"143","author":"E Biondetti","year":"2020","unstructured":"Biondetti, E. et al. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson\u2019s disease. Brain J. Neurol. 143, 2757\u20132770 (2020).","journal-title":"Brain J. Neurol."},{"key":"1174_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11910-022-01171-0","volume":"22","author":"ER de Natale","year":"2022","unstructured":"de Natale, E. R., Wilson, H. & Politis, M. Predictors of RBD progression and conversion to synucleinopathies. Curr. Neurol. Neurosci. Rep. 22, 93\u2013104 (2022).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"1174_CR35","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma, R. B. et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142, 744\u2013759 (2019).","journal-title":"Brain"},{"key":"1174_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/clockssleep7020019","volume":"7","author":"Y-W Shin","year":"2025","unstructured":"Shin, Y.-W. et al. Predicting phenoconversion in isolated RBD: machine learning and explainable AI approach. Clocks Sleep. 7, 19 (2025).","journal-title":"Clocks Sleep."},{"key":"1174_CR37","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1212\/WNL.0000000000003838","volume":"88","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases. Neurology 88, 1493\u20131500 (2017).","journal-title":"Neurology"},{"key":"1174_CR38","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1523\/JNEUROSCI.1907-15.2016","volume":"36","author":"J Acosta-Cabronero","year":"2016","unstructured":"Acosta-Cabronero, J., Betts, M. J., Cardenas-Blanco, A., Yang, S. & Nestor, P. J. In vivo MRI mapping of brain iron deposition across the adult lifespan. J. Neurosci. J. Soc. Neurosci. 36, 364\u2013374 (2016).","journal-title":"J. Neurosci. J. Soc. Neurosci."},{"key":"1174_CR39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s11682-018-9842-z","volume":"13","author":"X Guan","year":"2019","unstructured":"Guan, X. et al. Quantitative susceptibility mapping as a biomarker for evaluating white matter alterations in Parkinson\u2019s disease. Brain Imaging Behav. 13, 220\u2013231 (2019).","journal-title":"Brain Imaging Behav."},{"key":"1174_CR40","doi-asserted-by":"crossref","unstructured":"Ravanfar, P. et al. Systematic review: quantitative susceptibility mapping (QSM) of brain iron profile in neurodegenerative diseases. Front. Neurosci. 15, 618435(2021).","DOI":"10.3389\/fnins.2021.618435"},{"key":"1174_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/brain\/aww278","volume":"140","author":"J Acosta-Cabronero","year":"2017","unstructured":"Acosta-Cabronero, J. et al. The whole-brain pattern of magnetic susceptibility perturbations in Parkinson\u2019s disease. Brain 140, 118\u2013131 (2017).","journal-title":"Brain"},{"key":"1174_CR42","doi-asserted-by":"publisher","first-page":"e26675","DOI":"10.1002\/hbm.26675","volume":"45","author":"Z Varga","year":"2024","unstructured":"Varga, Z. et al. Whole brain pattern of iron accumulation in REM sleep behavior disorder. Hum. Brain Mapp. 45, e26675 (2024).","journal-title":"Hum. Brain Mapp."},{"key":"1174_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1148\/radiol.2017162486","volume":"287","author":"YJ Bae","year":"2018","unstructured":"Bae, Y. J. et al. Loss of substantia nigra hyperintensity at 3.0-T MR imaging in idiopathic REM sleep behavior disorder: comparison with 123I-FP-CIT SPECT. Radiology 287, 285\u2013293 (2018).","journal-title":"Radiology"},{"key":"1174_CR44","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/ana.24646","volume":"79","author":"R De Marzi","year":"2016","unstructured":"De Marzi, R. et al. Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder. Ann. Neurol. 79, 1026\u20131030 (2016).","journal-title":"Ann. Neurol."},{"key":"1174_CR45","doi-asserted-by":"publisher","first-page":"zsab131","DOI":"10.1093\/sleep\/zsab131","volume":"44","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Assessing brain iron and volume of subcortical nuclei in idiopathic rapid eye movement sleep behavior disorder. Sleep 44, zsab131 (2021).","journal-title":"Sleep"},{"key":"1174_CR46","first-page":"723","volume":"9","author":"L Ohlhauser","year":"2019","unstructured":"Ohlhauser, L., Smart, C. M. & Gawryluk, J. R. Tract-based spatial statistics reveal lower white matter integrity specific to idiopathic rapid eye movement sleep behavior disorder as a proxy for prodromal Parkinson\u2019s disease. J. Park. Dis. 9, 723\u2013731 (2019).","journal-title":"J. Park. Dis."},{"key":"1174_CR47","first-page":"119","volume":"10","author":"S Pujol","year":"2016","unstructured":"Pujol, S. et al. In vivo exploration of the connectivity between the subthalamic nucleus and the Globus Pallidus in the human brain using multi-fiber tractography. Front. Neuroanat. 10, 119 (2016).","journal-title":"Front. Neuroanat."},{"key":"1174_CR48","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/mrm.25420","volume":"74","author":"C Wisnieff","year":"2015","unstructured":"Wisnieff, C. et al. Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron. Magn. Reson. Med. 74, 564\u2013570 (2015).","journal-title":"Magn. Reson. Med."},{"key":"1174_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/0166-2236(90)90112-N","volume":"13","author":"MJ Zigmond","year":"1990","unstructured":"Zigmond, M. J., Abercrombie, E. D., Berger, T. W., Grace, A. A. & Stricker, E. M. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci. 13, 290\u2013296 (1990).","journal-title":"Trends Neurosci."},{"key":"1174_CR50","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1002\/ana.21481","volume":"64","author":"JA Obeso","year":"2008","unstructured":"Obeso, J. A. et al. The basal ganglia in Parkinson\u2019s disease: current concepts and unexplained observations. Ann. Neurol. 64, S30\u2013S46 (2008).","journal-title":"Ann. Neurol."},{"key":"1174_CR51","doi-asserted-by":"publisher","first-page":"13718","DOI":"10.1523\/JNEUROSCI.5750-11.2012","volume":"32","author":"KY Fan","year":"2012","unstructured":"Fan, K. Y., Baufreton, J., Surmeier, D. J., Chan, C. S. & Bevan, M. D. Proliferation of external Globus Pallidus-subthalamic nucleus synapses following degeneration of midbrain dopamine neurons. J. Neurosci. 32, 13718\u201313728 (2012).","journal-title":"J. Neurosci."},{"key":"1174_CR52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.expneurol.2017.10.002","volume":"298","author":"J Blesa","year":"2017","unstructured":"Blesa, J. et al. Compensatory mechanisms in Parkinson\u2019s disease: circuits adaptations and role in disease modification. Exp. Neurol. 298, 148\u2013161 (2017).","journal-title":"Exp. Neurol."},{"key":"1174_CR53","doi-asserted-by":"publisher","first-page":"e0118907","DOI":"10.1371\/journal.pone.0118907","volume":"10","author":"M Syka","year":"2015","unstructured":"Syka, M. et al. Correlation between relaxometry and diffusion tensor imaging in the Globus Pallidus of Huntington\u2019s disease patients. PLoS ONE 10, e0118907 (2015).","journal-title":"PLoS ONE"},{"key":"1174_CR54","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/jmri.24065","volume":"38","author":"AM Rulseh","year":"2013","unstructured":"Rulseh, A. M., Keller, J., Tint\u011bra, J., Ko\u017e\u00ed\u0161ek, M. & Vymazal, J. Chasing shadows: What determines DTI metrics in gray matter regions? An in vitro and in vivo study. J. Magn. Reson. Imaging 38, 1103\u20131110 (2013).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1174_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep40779","volume":"7","author":"R Zhu","year":"2017","unstructured":"Zhu, R., Xie, C., Hu, P. & Wang, K. Clinical variations in Parkinson\u2019s disease patients with or without REM sleep behaviour disorder: a meta-analysis. Sci. Rep. 7, 40779 (2017).","journal-title":"Sci. Rep."},{"key":"1174_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.sleep.2016.07.003","volume":"24","author":"J Bu\u0161kov\u00e1","year":"2016","unstructured":"Bu\u0161kov\u00e1, J., Ibarburu, V., \u0160onka, K. & R\u016f\u017ei\u010dka, E. Screening for REM sleep behavior disorder in the general population. Sleep. Med. 24, 147 (2016).","journal-title":"Sleep. Med."},{"key":"1174_CR57","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia, M. J. International classification of sleep disorders-third edition: highlights and modifications. Chest 146, 1387\u20131394 (2014).","journal-title":"Chest"},{"key":"1174_CR58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mds.21198","volume":"22","author":"CG Goetz","year":"2007","unstructured":"Goetz, C. G. et al. Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov. Disord. J. Mov. Disord. Soc. 22, 41\u201347 (2007).","journal-title":"Mov. Disord. J. Mov. Disord. Soc."},{"key":"1174_CR59","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0031-9384(84)90269-5","volume":"32","author":"RL Doty","year":"1984","unstructured":"Doty, R. L., Shaman, P. & Dann, M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol. Behav. 32, 489\u2013502 (1984).","journal-title":"Physiol. Behav."},{"key":"1174_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/23279095.2015.1065261","volume":"24","author":"M Kopecek","year":"2017","unstructured":"Kopecek, M. et al. Montreal cognitive assessment (MoCA): normative data for old and very old Czech adults. Appl. Neuropsychol. Adult 24, 23\u201329 (2017).","journal-title":"Appl. Neuropsychol. Adult"},{"key":"1174_CR61","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"1174_CR62","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/mds.21844","volume":"22","author":"B Dubois","year":"2007","unstructured":"Dubois, B. et al. Diagnostic procedures for Parkinson\u2019s disease dementia: recommendations from the movement disorder society task force. Mov. Disord. J. Mov. Disord. Soc. 22, 2314\u20132324 (2007).","journal-title":"Mov. Disord. J. Mov. Disord. Soc."},{"key":"1174_CR63","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89, 88\u2013100 (2017).","journal-title":"Neurology"},{"key":"1174_CR64","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00259-009-1267-x","volume":"37","author":"J Darcourt","year":"2010","unstructured":"Darcourt, J. et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur. J. Nucl. Med. Mol. Imaging 37, 443\u2013450 (2010).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1174_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51710-y","volume":"9","author":"P Du\u0161ek","year":"2019","unstructured":"Du\u0161ek, P. et al. Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder. Sci. Rep. 9, 15463 (2019).","journal-title":"Sci. Rep."},{"key":"1174_CR66","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1002\/mrm.26963","volume":"79","author":"K Eckstein","year":"2018","unstructured":"Eckstein, K. et al. Computationally efficient combination of multi-channel phase data from multi-echo acquisitions (ASPIRE). Magn. Reson. Med. 79, 2996\u20133006 (2018).","journal-title":"Magn. Reson. Med."},{"key":"1174_CR67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuroimage.2018.07.065","volume":"183","author":"J Acosta-Cabronero","year":"2018","unstructured":"Acosta-Cabronero, J. et al. A robust multi-scale approach to quantitative susceptibility mapping. NeuroImage 183, 7\u201324 (2018).","journal-title":"NeuroImage"},{"key":"1174_CR68","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.neuroimage.2004.07.030","volume":"23","author":"SS Keller","year":"2004","unstructured":"Keller, S. S., Wilke, M., Wieshmann, U. C., Sluming, V. A. & Roberts, N. Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. NeuroImage 23, 860\u2013868 (2004).","journal-title":"NeuroImage"},{"key":"1174_CR69","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W. & Smith, S. M. FSL. NeuroImage 62, 782\u2013790 (2012).","journal-title":"NeuroImage"},{"key":"1174_CR70","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuroimage.2016.05.024","volume":"138","author":"MJ Betts","year":"2016","unstructured":"Betts, M. J., Acosta-Cabronero, J., Cardenas-Blanco, A., Nestor, P. J. & D\u00fczel, E. High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T. NeuroImage 138, 43\u201363 (2016).","journal-title":"NeuroImage"},{"key":"1174_CR71","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul, F., Erdfelder, E., Lang, A.-G. & Buchner, A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39, 175\u2013191 (2007).","journal-title":"Behav. Res. Methods"},{"key":"1174_CR72","doi-asserted-by":"publisher","unstructured":"Robin, X. et al. pROC: Display and Analyze ROC Curves. 1.18.5. https:\/\/doi.org\/10.32614\/CRAN.package.pROC (2010).","DOI":"10.32614\/CRAN.package.pROC"},{"key":"1174_CR73","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch, P. M. & Therneau, T. M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81, 515\u2013526 (1994).","journal-title":"Biometrika"},{"key":"1174_CR74","unstructured":"Therneau, T. M. A Package for Survival Analysis in R. R package version 3.8-3. https:\/\/CRAN.R-project.org\/package=survival (2024)."},{"key":"1174_CR75","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","volume":"48","author":"P Peduzzi","year":"1995","unstructured":"Peduzzi, P., Concato, J., Feinstein, A. R. & Holford, T. R. Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates. J. Clin. Epidemiol. 48, 1503\u20131510 (1995).","journal-title":"J. Clin. Epidemiol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01174-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01174-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01174-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:02:32Z","timestamp":1763733752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01174-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01174-x","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"22 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}